XtalPi and EDDC collaborate in AI-empowered drug discovery program for Non-Small Cell Lung Cancer

XtalPi joins hands with Singapore’s national platform for drug discovery and development to discover more effective treatment options for cancer patients worldwide. In this collaboration, XtalPi will leverage its quantum physics and AI-driven platform, while EDDC provides valuable insight and data on the novel NSCLC target, to accelerate the drug discovery process and propel the program towards development.


Click here to read more about it.

Related Articles